Nomination Period Closing June 23 for PCMP Breast Cancer Screening Clinician Expert Workgroup

As a reminder, The Centers for Medicare & Medicaid Services (CMS) and its measure developer are seeking nominations for the Clinician Expert Workgroup that will provide input on the development of the Breast Cancer Screening episode-based cost measure for potential use in the Quality Payment Program (QPP). Interested clinicians are invited to submit nominations between now and June 23, 2025, at 11:59 p.m. ET with the first workgroup meeting scheduled to occur in July 2025. 

Individuals interested in joining the Wave 7 Breast Cancer Screening workgroup may submit their nomination through this online nomination form.

Please note, this workgroup nomination period is for the breast cancer screening measure being specified as a cost measure at the clinician/group-level. Separately, CMS is also hosting the OP-39 Re-Specification TEP, which is working on facility-based quality measurement for breast cancer screening. There are no restrictions to participating in this upcoming Clinician Expert Workgroup if you are also interested in participating in the OP-39 Re-Specification TEP (under the “Development, Reevaluation, and Implementation of Outpatient Outcome/Efficiency Measures” project). While these two measures are clinically related topics, the clinician expert panels will be developing different types of measures (cost vs. quality) for different settings (clinician/groups vs. facilities).

For more information, please refer to the Call for Nominations posting website or the nomination form. If you have any questions or would like to request a 508-compliant version of the nomination form, please contact the Acumen PCMP Workgroup Support Team at pcmp-workgroup-support@acumenllc.com.